3D Interaction,drug ligand name,target,Uniprot code,n_ca_T,n_ca_M,n_local_pairs,local_rmsd,local_coverage,vendor,smiles,clinical_phase,moa,database,cids,target chain id,chain name,Align Length,Binding_Affinity_kcal/mol
2GDO_12C_Q6PLK2.pdb,12C,2GDO,Q6PLK2,269,446,134,0.636,0.498,Selleck,Clc1ccc2[nH]c(=O)c(-c3nc4ccccc4[nH]3)c(N[C@@H]3CN4CCC3CC4)c2c1,Preclinical,CHK inhibitor,Uniprot,135399748,A,,250,-8.16
2GDO_12C_P62343.pdb,12C,2GDO,P62343,269,524,112,0.684,0.416,Selleck,Clc1ccc2[nH]c(=O)c(-c3nc4ccccc4[nH]3)c(N[C@@H]3CN4CCC3CC4)c2c1,Preclinical,CHK inhibitor,Uniprot,135399748,A,,283,-10.16
